Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A R Crossman

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Brain Research. Molecular Brain Research|July 1, 1989
Cellular localisation of enkephalin gene expression in MPTP-treated cynomolgus monkeysS J Augood, P C Emson, I J Mitchell, et al.
Brain Research|April 23, 1990
Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. II. Unilateral intra-carotid infusion of MPTP in the monkey (Macaca fascicularis)W C Graham, C E Clarke, S Boyce, et al.
Experimental Neurology|June 12, 2004
Selective blockade of D(3) dopamine receptors enhances the anti-parkinsonian properties of ropinirole and levodopa in the MPTP-lesioned primateM A Silverdale, S L Nicholson, P Ravenscroft, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 16, 1998
Kappa-opioid receptor agonists increase locomotor activity in the monoamine-depleted rat model of parkinsonismN R Hughes, A T McKnight, G N Woodruff, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1990
Neural mechanisms of dystonia: evidence from a 2-deoxyglucose uptake study in a primate model of dopamine agonist-induced dystoniaI J Mitchell, R Luquin, S Boyce, et al.
Neuroscience|January 1, 1989
Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineI J Mitchell, C E Clarke, S Boyce, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1990
Induction of chorea and dystonia in parkinsonian primatesS Boyce, C E Clarke, R Luquin, et al.
Neuropharmacology|March 10, 2005
Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's diseaseP J Hallett, A W Dunah, P Ravenscroft, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 23, 2001
Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's diseaseE Bezard, S Dovero, C Prunier, et al.
Brain Research|March 29, 1988
Unilateral MPTP lesion in a rhesus monkey: effects on the striatal dopaminergic system measured in vivo with PET using various novel tracersK L Leenders, S M Aquilonius, K Bergström, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Brain Research. Molecular Brain Research|July 1, 1989
Cellular localisation of enkephalin gene expression in MPTP-treated cynomolgus monkeysS J Augood, P C Emson, I J Mitchell, et al.
Brain Research|April 23, 1990
Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. II. Unilateral intra-carotid infusion of MPTP in the monkey (Macaca fascicularis)W C Graham, C E Clarke, S Boyce, et al.
Experimental Neurology|June 12, 2004
Selective blockade of D(3) dopamine receptors enhances the anti-parkinsonian properties of ropinirole and levodopa in the MPTP-lesioned primateM A Silverdale, S L Nicholson, P Ravenscroft, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 16, 1998
Kappa-opioid receptor agonists increase locomotor activity in the monoamine-depleted rat model of parkinsonismN R Hughes, A T McKnight, G N Woodruff, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1990
Neural mechanisms of dystonia: evidence from a 2-deoxyglucose uptake study in a primate model of dopamine agonist-induced dystoniaI J Mitchell, R Luquin, S Boyce, et al.
Neuroscience|January 1, 1989
Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineI J Mitchell, C E Clarke, S Boyce, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1990
Induction of chorea and dystonia in parkinsonian primatesS Boyce, C E Clarke, R Luquin, et al.
Neuropharmacology|March 10, 2005
Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's diseaseP J Hallett, A W Dunah, P Ravenscroft, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 23, 2001
Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's diseaseE Bezard, S Dovero, C Prunier, et al.
Brain Research|March 29, 1988
Unilateral MPTP lesion in a rhesus monkey: effects on the striatal dopaminergic system measured in vivo with PET using various novel tracersK L Leenders, S M Aquilonius, K Bergström, et al.
Pageof 10